| Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours A Mansurov, J Ishihara, P Hosseinchi, L Potin, TM Marchell, A Ishihara, ... Nature Biomedical Engineering 4 (5), 531-543, 2020 | 157 | 2020 |
| Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events J Ishihara, K Fukunaga, A Ishihara, HM Larsson, L Potin, P Hosseinchi, ... Science Translational Medicine 9 (415), 2017 | 156 | 2017 |
| Targeted antibody and cytokine cancer immunotherapies through collagen affinity J Ishihara, A Ishihara, K Sasaki, SSY Lee, JM Williford, M Yasui, H Abe, ... Science translational medicine 11 (487), 2019 | 154 | 2019 |
| Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy JM Williford, J Ishihara, A Ishihara, A Mansurov, P Hosseinchi, ... Science Advances 5 (12), eaay1357, 2019 | 107 | 2019 |
| Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker A Mansurov, P Hosseinchi, K Chang, AL Lauterbach, LT Gray, AT Alpar, ... Nature Biomedical Engineering, 1-11, 2022 | 41 | 2022 |
| Improving efficacy and safety of agonistic anti-CD40 antibody through extracellular matrix affinity J Ishihara, A Ishihara, L Potin, P Hosseinchi, K Fukunaga, M Damo, ... Molecular cancer therapeutics 17 (11), 2399-2411, 2018 | 40 | 2018 |
| Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis A Ishihara, J Ishihara, EA Watkins, AC Tremain, M Nguyen, A Solanki, ... Nature Biomedical Engineering, 1-12, 2020 | 29 | 2020 |
| Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models E Yuba, E Budina, K Katsumata, A Ishihara, A Mansurov, AT Alpar, ... ARTHRITIS & RHEUMATOLOGY, 2021 | 18 | 2021 |
| Enhanced lymph node trafficking of engineered IL‐10 suppresses rheumatoid arthritis in murine models E Yuba, E Budina, K Katsumata, A Ishihara, A Mansurov, AT Alpar, ... Arthritis & Rheumatology, 2020 | 2 | 2020 |
| Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis (Oct, 10.1038/s41551-020-00627-3, 2020) A Ishihara, J Ishihara, EA Watkins, AC Tremain, M Nguyen, A Solanki, ... NATURE BIOMEDICAL ENGINEERING 4 (11), 1117-1117, 2020 | 2 | 2020 |
| Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through J Ishihara, A Ishihara, L Potin, P Hosseinchi, K Fukunaga, M Damo, ... | 1 | |
| Publisher Correction: Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis A Ishihara, J Ishihara, EA Watkins, AC Tremain, M Nguyen, A Solanki, ... Nature biomedical engineering 4 (11), 1117, 2020 | | 2020 |
| Induction of lymphangiogenesis in breast cancer enhances responsiveness to immunotherapies P Hosseinchi, A Mansurov, L Maillat, L Potin, G Fujimori, JA Hubbell, ... Cancer Research 80 (16 Supplement), 5695-5695, 2020 | | 2020 |
| Abstract B97: The immunomodulatory roles of tumor-associated lymphatics in triple-negative breast cancer P Hosseinchi, L Potin, A Mansurov, L Maillat, JA Hubbell, MA Swartz Cancer Immunology Research 8 (3 Supplement), B97-B97, 2020 | | 2020 |
| Collagen affinity improves safety and efficacy of antibody and cytokine cancer immunotherapies J Ishihara, A Ishihara, A Mansurov, K Sasaki, SS Lee, JM Williford, L Potin, ... Cancer Research 79 (13 Supplement), 1553-1553, 2019 | | 2019 |
| Abstract IA07: Using matrix protein affinity to modulate the tumor microenvironment J Ishihara, A Ishihara, K Saskai, SSY Lee, M Yasui, H Abe, L Potin, ... Cancer Immunology Research 7 (2 Supplement), IA07-IA07, 2019 | | 2019 |
| Extracellular matrix-binding immunotherapies show enhanced antitumor efficacy and reduced adverse events J Ishihara, A Ishihara, K Fukunaga, L Potin, P Hosseinchi, MA Swartz, ... Cancer Research 78 (13 Supplement), 959-959, 2018 | | 2018 |
Jeffrey HubbellUniversity of ChicagoVerified email at uchicago.edu
